HIV-1 Vaccine Shows Strong T-Cell Response in Phase 1 Study ...Middle East

Medscape - News
HIV-1 Vaccine Shows Strong T-Cell Response in Phase 1 Study
According to a phase 1 trial, the experimental HIVconsvX vaccine is safe and immunogenic among sub-Saharan African participants who bear the highest burden of HIV-1. Medscape Medical News

Hence then, the article about hiv 1 vaccine shows strong t cell response in phase 1 study was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( HIV-1 Vaccine Shows Strong T-Cell Response in Phase 1 Study )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News